Certolizumab pegol in a heterogeneous population of patients with moderate-to-severe rheumatoid arthritis.
about
Certolizumab pegol in a heterogeneous population of patients with moderate-to-severe rheumatoid arthritis.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Certolizumab pegol in a hetero ...... o-severe rheumatoid arthritis.
@en
Certolizumab pegol in a hetero ...... o-severe rheumatoid arthritis.
@nl
type
label
Certolizumab pegol in a hetero ...... o-severe rheumatoid arthritis.
@en
Certolizumab pegol in a hetero ...... o-severe rheumatoid arthritis.
@nl
prefLabel
Certolizumab pegol in a hetero ...... o-severe rheumatoid arthritis.
@en
Certolizumab pegol in a hetero ...... o-severe rheumatoid arthritis.
@nl
P2093
P2860
P356
P1433
P1476
Certolizumab pegol in a hetero ...... o-severe rheumatoid arthritis.
@en
P2093
Analia Dellepiane
Carlos Baruzzo
Cristian Alejandro Benítez
Enrique R Soriano
Gabriela Salvatierra
Rodrigo Garcia Salinas
P2860
P304
P356
10.4155/FSOA-2017-0149
P577
2018-02-15T00:00:00Z